Home LiteratureArticle Details
PMID: 17689071 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Human 3beta-hydroxysteroid dehydrogenase types 1 and 2: Gene sequence variation and functional genomics.

The Journal of steroid biochemistry and molecular biology ·Vol. 107 ·No. 1-2 ·2007-10-00 ·Pages 88-99

Wang L, Salavaggione E, Pelleymounter L, Eckloff B, Wieben E, Weinshilboum R

Abstract

The 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase isoenzymes 1 and 2 (HSD3B1 and HSD3B2) are membrane-bound enzymes that play essential roles in the biosynthesis of steroid hormones. Therefore, variation in the HSD3B1 and HSD3B2 genes might play a role in the pathophysiology of steroid hormone-related disease. We set out to systematically identify common polymorphisms and haplotypes in human HSD3B1 and HSD3B2. We identified 17 single nucleotide polymorphisms (SNPs) in HSD3B1 and 9 in HSD3B2 - the majority of which were not present in public databases - by resequencing human HSD3B1 and HSD3B2 using 240 DNA samples from four different ethnic groups (60 samples per group). Functional genomic studies of the five non-synonymous cSNPs in HSD3B1 and the one observed in HSD3B2 showed that two of these polymorphisms resulted in significant decreases in the quantity of enzyme protein expressed. However, none of the three non-synonymous SNPs located in areas encoding putative membrane-binding domains altered subcellular localization of the enzyme as determined by immunofluorescence microscopy. Finally, common variant haplotypes in the 5'-flanking regions of these genes showed significant cell line-dependent variation in their ability to drive transcription. In aggregate, these results provide a basis for study of the possible role in human disease of common genetic variation in HSD3B1 and HSD3B2.

MeSH Terms
3-Hydroxysteroid Dehydrogenases/genetics,metabolism 5' Flanking Region Animals COS Cells Chlorocebus aethiops Genes, Reporter Genetic Variation Genomics Haplotypes Humans Linkage Disequilibrium Microscopy, Confocal Polymorphism, Single Nucleotide Protein Structure, Tertiary Reverse Transcriptase Polymerase Chain Reaction
Chemicals
3-Hydroxysteroid Dehydrogenases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Wang Liewei
Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. [email protected]
Salavaggione Ezequiel
Pelleymounter Linda
Eckloff Bruce
Wieben Eric
Weinshilboum Richard
References (43)
43 references, click to expand
  1. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
    Mol Endocrinol. 1999 Jan;13(1):66-81 PMID: 9892013
  2. Characterization of the 3 beta-hydroxysteroid dehydrogenase activity associated with bovine adrenocortical mitochondria.
    Endocrinology. 1994 Mar;134(3):1358-64 PMID: 8119176
  3. Stat5-mediated regulation of the human type II 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene: activation by prolactin.
    Mol Endocrinol. 1999 Jul;13(7):1084-93 PMID: 10406460
  4. Induction of 3beta-hydroxysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines.
    Endocrinology. 1999 Oct;140(10):4573-84 PMID: 10499513
  5. Creation of a fully active, cytosolic form of human type I 3beta-hydroxysteroid dehydrogenase/isomerase by the deletion of a membrane-spanning domain.
    J Mol Endocrinol. 1999 Oct;23(2):231-9 PMID: 10514560
  6. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.
    Endocr Rev. 2004 Dec;25(6):947-70 PMID: 15583024
  7. Beta2-adrenoceptor gene polymorphisms.
    Pharmacogenet Genomics. 2005 May;15(5):267-75 PMID: 15864127
  8. Regulation of mammary gland factor/Stat5a during mammary gland development.
    Mol Endocrinol. 1995 Nov;9(11):1598-609 PMID: 8584036
  9. Molecular biology and genetics of the 3 beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family.
    J Endocrinol. 1996 Sep;150 Suppl:S189-207 PMID: 8943802
  10. The multiple murine 3 beta-hydroxysteroid dehydrogenase isoforms: structure, function, and tissue- and developmentally specific expression.
    Steroids. 1997 Jan;62(1):169-75 PMID: 9029733
  11. Structure-function relationships of 3 beta-hydroxysteroid dehydrogenase: contribution made by the molecular genetics of 3 beta-hydroxysteroid dehydrogenase deficiency.
    Steroids. 1997 Jan;62(1):176-84 PMID: 9029734
  12. Synergistic activation of the human type II 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase promoter by the transcription factor steroidogenic factor-1/adrenal 4-binding protein and phorbol ester.
    J Biol Chem. 1997 Mar 21;272(12):7960-7 PMID: 9065466
  13. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing.
    Nucleic Acids Res. 1997 Jul 15;25(14):2745-51 PMID: 9207020
  14. Consed: a graphical tool for sequence finishing.
    Genome Res. 1998 Mar;8(3):195-202 PMID: 9521923
  15. Functional activity of 3beta-hydroxysteroid dehydrogenase/isomerase.
    Endocr Res. 1998 Aug-Nov;24(3-4):549-57 PMID: 9888536
  16. Human aromatase: gene resequencing and functional genomics.
    Cancer Res. 2005 Dec 1;65(23):11071-82 PMID: 16322257
  17. Human phenylethanolamine N-methyltransferase pharmacogenomics: gene re-sequencing and functional genomics.
    J Neurochem. 2005 Dec;95(6):1766-76 PMID: 16277617
  18. Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia.
    Prostate. 2006 Mar 1;66(4):392-404 PMID: 16302261
  19. Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies.
    J Biol Chem. 2006 Mar 17;281(11):7364-73 PMID: 16407288
  20. Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics.
    Pharmacogenet Genomics. 2006 Apr;16(4):265-77 PMID: 16538173
  21. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.
    Oncogene. 2006 Mar 13;25(11):1629-38 PMID: 16550163
  22. Glutathione S-transferase omega 1 and omega 2 pharmacogenomics.
    Drug Metab Dispos. 2006 Jul;34(7):1237-46 PMID: 16638819
  23. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family.
    Endocr Rev. 2005 Jun;26(4):525-82 PMID: 15632317
  24. Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation.
    Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9394-9 PMID: 15967990
  25. The International HapMap Project Web site.
    Genome Res. 2005 Nov;15(11):1592-3 PMID: 16251469
  26. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism.
    Am J Hum Genet. 2000 Oct;67(4):881-900 PMID: 10986041
  27. The engineered, cytosolic form of human type I 3beta-hydroxysteroid dehydrogenase/isomerase: purification, characterization and crystallization.
    J Mol Endocrinol. 2001 Aug;27(1):77-83 PMID: 11463578
  28. Score tests for association between traits and haplotypes when linkage phase is ambiguous.
    Am J Hum Genet. 2002 Feb;70(2):425-34 PMID: 11791212
  29. Structure/function relationships responsible for the kinetic differences between human type 1 and type 2 3beta-hydroxysteroid dehydrogenase and for the catalysis of the type 1 activity.
    J Biol Chem. 2002 Nov 8;277(45):42795-801 PMID: 12205101
  30. Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency.
    Semin Reprod Med. 2002 Aug;20(3):255-76 PMID: 12428206
  31. Thiopurine S-methyltransferase pharmacogenetics: chaperone protein association and allozyme degradation.
    Pharmacogenetics. 2003 Sep;13(9):555-64 PMID: 12972954
  32. Pharmacogenetics: inherited variation in amino acid sequence and altered protein quantity.
    Clin Pharmacol Ther. 2004 Apr;75(4):253-8 PMID: 15080131
  33. [Congenital adrenal hyperplasia (21-OH) in France. Population genetics].
    Arch Fr Pediatr. 1985 Mar;42(3):175-9 PMID: 3873926
  34. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.
    Genetics. 1989 Nov;123(3):585-95 PMID: 2513255
  35. Congenital adrenal hyperplasia in Sweden 1969-1986. Prevalence, symptoms and age at diagnosis.
    Acta Paediatr Scand. 1990 Feb;79(2):168-75 PMID: 2321478
  36. Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells.
    J Biol Chem. 1990 Nov 25;265(33):20469-75 PMID: 2243100
  37. Structural analysis of the gene encoding human 3 beta-hydroxysteroid dehydrogenase/delta 5----4-isomerase.
    Mol Endocrinol. 1990 Dec;4(12):1850-5 PMID: 2082186
  38. Structure of the human type II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) gene: adrenal and gonadal specificity.
    DNA Cell Biol. 1991 Dec;10(10):701-11 PMID: 1741954
  39. Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells.
    J Biol Chem. 1992 Feb 15;267(5):3551 PMID: 1737804
  40. Affinity radiolabeling identifies peptides and amino acids associated with substrate binding in human placental 3 beta-hydroxy-delta(5)-steroid dehydrogenase.
    J Biol Chem. 1993 Sep 5;268(25):18507-12 PMID: 8360152
  41. Dual subcellular localization of the 3 beta-hydroxysteroid dehydrogenase isomerase: characterization of the mitochondrial enzyme in the bovine adrenal cortex.
    J Steroid Biochem Mol Biol. 1993 Dec;46(6):773-9 PMID: 8274411
  42. Topology of 3 beta-hydroxy-5-ene-steroid dehydrogenase/delta 5-delta 4-isomerase in adrenal cortex mitochondria and microsomes.
    Endocrinology. 1994 Feb;134(2):751-9 PMID: 8299570
  43. DNA sequence variation in a non-coding region of low recombination on the human X chromosome.
    Nat Genet. 1999 May;22(1):78-81 PMID: 10319866
Article Info
Journal
The Journal of steroid biochemistry and molecular biology
Abbr.
J Steroid Biochem Mol Biol
ISSN
0960-0760
Published
2007-10-00
Epub
2007-00-08
Pages
88-99
Language
English
Region
England
NLM ID
9015483
PMCID
PMC2755580
Subset
IM
Grants
NIGMS NIH HHS · U01 GM61388 · United States
NIGMS NIH HHS · R01 GM35720 · United States
NIGMS NIH HHS · R01 GM028157 · United States
NIGMS NIH HHS · R01 GM035720-21 · United States
NIGMS NIH HHS · U01 GM061388 · United States
NIGMS NIH HHS · R01 GM035720 · United States
NIGMS NIH HHS · R01 GM28157 · United States
NIGMS NIH HHS · U01 GM061388-09 · United States
NIGMS NIH HHS · R01 GM028157-28 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]